What platelet‑rich plasma (PRP) protocol, efficacy, and safety profile are recommended for an adult with androgenetic (non‑scarring) hair loss, and how can adjunct exosome therapy be incorporated?

PRP and Exosome Therapy for Androgenetic Alopecia

Primary Recommendation

Administer PRP as three intradermal scalp injections spaced exactly one month apart (months 0,1, and 2), combined with topical minoxidil 5% twice daily, which demonstrates a 1.74-fold increase in hair density and 14.3-fold increase in hair diameter at 6 months compared to baseline. 1

---

Standard PRP Protocol

Blood Collection and Preparation

• Draw autologous blood and process immediately using manual double-spin centrifugation targeting 1.0-1.5 million platelets per microliter 2
• Use nonactivated PRP exclusively—activation reduces efficacy by 31% compared to nonactivated preparations 1, 2

Injection Technique

• Deliver 5-7 mL PRP per session using 30-gauge × 4 mm needles 1, 2
• Insert needles at 90-degree angle perpendicular to scalp surface 3
• Inject at 2-4 mm depth to reach dermal papilla cells 3
• Space injection points 1 cm apart in systematic grid pattern across entire affected area 3
• Apply pharmaceutical-grade topical anesthetic before injection to minimize pain 2

Treatment Schedule

• Initial phase: Three sessions at months 0,1, and 2 1, 2
• Maintenance phase: Injections every 6 months indefinitely to sustain results 1, 2, 3
• Discontinuation results in progressive hair loss within 12-16 months 4

---

Mandatory Concurrent Therapy

PRP combined with topical minoxidil 5% is significantly more effective than either monotherapy and both are superior to placebo. 5, 2

• Apply minoxidil 5% at 1 mL twice daily throughout treatment and continue indefinitely 1, 2
• Consider adding finasteride as background therapy for triple combination (PRP + minoxidil + finasteride), which represents the most effective evidence-based approach 1, 3

---

Expected Outcomes and Timeline

Early Response (2-3 Months)

• Initial improvements in hair density become visible at 2-3 months 1, 2
• Hair thickness increases within 1 month after first injection 6
• Hair loss reduction evident after 3 months 6
• A 25% improvement in hair density at 2 months predicts sustained response at 6 months 1

Peak Response (6 Months)

• Hair density increases by 1.74 times baseline 1, 2
• Hair diameter increases by 14.3 times baseline 1, 2
• Mean increase of 45.9 hairs per cm² compared to baseline 4
• Telogen phase hair decreases by 9.3 times 2
• Terminal to vellus hair ratio increases in 60% of patients 7

Long-Term Maintenance

• Progressive improvement continues until 12 months 6
• Maintenance injections every 6 months required to prevent relapse 1, 2

---

Efficacy Considerations

Patient Selection

• PRP shows particular value in mild-to-moderate androgenetic alopecia, with more severe grades showing variable results 1, 2
• Women may demonstrate greater efficacy than men in hair growth/production 6

Critical Success Factors

• Higher platelet concentrations produce greater effects on hair density, follicle diameter, and terminal hair density 5
• Adequate volume of PRP (5-7 mL per session) is essential 5
• Treatment frequency must be maintained—inadequate frequency leads to failure 5

Application Method Comparison

• Microneedling delivery is superior to standard injection technique for anagen phase, telogen phase, and average hair length 5

---

Safety Profile

• Pain during injection is the primary complaint, with minimal morbidity and low cost 1
• No serious adverse events reported across multiple trials 4, 8, 7, 9
• Minoxidil is better tolerated than PRP due to injection-related pain 5
• PRP demonstrates satisfactory safety profile with no remarkable adverse effects 6, 7

---

Monitoring Treatment Response

Objective Measurements

• Use trichoscopy to evaluate hair density and diameter at 2,3, and 6 months 1
• Perform hair counts in specific scalp areas before and after treatment 5
• Measure hair shaft diameter using micrometer or specialized tools 5
• Conduct trichogram analysis using computer software to measure hair density, diameter, and terminal/vellus ratio 5

Clinical Assessment

• Take standardized before-and-after photographs for visual comparison 5, 1
• Perform pull test to assess hair fragility—fewer hairs indicate improved strength 5
• Use Global Physician Assessment (GPA) scoring 5
• Administer patient self-assessment questionnaires for satisfaction 5, 1

---

Exosome Therapy Integration

Currently, there is no high-quality guideline or research evidence supporting exosome therapy for androgenetic alopecia in the provided literature. The evidence base focuses exclusively on PRP, with emerging interest in platelet-rich fibrin (PRF) as an alternative.

Alternative to Consider: Platelet-Rich Fibrin (PRF)

• PRF is emerging as a potentially superior alternative to PRP, offering theoretical advantages with similar efficacy and lower cost 1, 2
• PRF demonstrates clinical efficacy in androgenetic alopecia with a similar safety profile to PRP 2
• PRF preparation is easier and less expensive than PRP 2

---

Critical Pitfalls to Avoid

Preparation Errors

• Never use activated PRP—nonactivated PRP produces 31% greater increases in hair count and total hair density 1, 2, 3
• Ensure adequate platelet concentration (1.0-1.5 million/μL)—low concentrations lead to treatment failure 5, 2

Protocol Deviations

• Do not skip maintenance injections—results are lost within 12-16 months without ongoing treatment 1, 2, 3, 4
• Do not use PRP monotherapy—combination with minoxidil 5% is significantly more effective 5, 1, 2
• Do not inject superficially—maintain 2-4 mm depth to target dermal papilla cells 3

Coverage Issues

• Inject across entire affected area in systematic grid pattern—incomplete coverage reduces efficacy 3
• Do not concentrate PRP in single area—distribute evenly across all treatment zones 3

---

Mechanistic Evidence

PRP increases proliferative activity of hair follicle cells as measured by β-catenin, CD34, Ki67, and Dkk-1 antibodies 5

Histologic improvements include:

• Increased number of basal keratinocytes 5
• Improved epidermal thickness 5, 4
• Increased number of hair follicles 4
• Increased Ki67+ keratinocytes in epidermis and follicular bulge cells 4
• Slight increase in small blood vessels around hair follicles 4

---

Evidence Quality and Limitations

The evidence for PRP remains somewhat controversial due to highly variable study protocols, preparations, and treatment intervals across studies 1. Meta-analysis of 9 randomized controlled trials involving 238 patients demonstrates statistically significant increases in hair density at 3 and 6 months compared to placebo 9. However, improved and standardized study designs with larger samples, quantitative measurements, and longer follow-up periods are needed 1.